Keeping Track Of Review Designations: BTDs For X4, F2G, And BMS; Another QIDP For Allergan

 
• By Bridget Silverman and Michael Cipriano

The latest news about products accepted into US FDA expedited review programs.

Keeping Track Feature image

More from US FDA Performance Tracker

More from Regulatory Trackers